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As evidenced-based stroke care continues to evolve more alternatives 
are available to enable life-saving intervention for acute ischemic stroke 
patients.  This presents new challenges in providing the best plan of care 
which now extends beyond FDA approved intravenous alteplase to include 
mechanical interventions that further extends the treatment time.  Nurses 
play a pivotal role in all phases of care and therefore need to gain a deeper 
understanding in the decision making in the first twenty four hours.  This 
poster will review the current use of imaging to guide and support clinical 
intervention and clarify differences between treatment time windows for 
acute ischemic stroke.  As important as early treatment, careful oversight 
of performance criteria ensures safe delivery of care and facilitates 
achievement of best patient outcomes.  Participants will analyze quality 
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•  Identify the inclusion/exclusion criteria for use of intravenous alteplase.
•  Describe the decision making in extending the window for intravenous alteplase.
•  Apply data available from multi modality imaging and advanced endovascular 
techniques to provide acute stroke rescue.
Strategies for Best Practice:
• Develop standard work processes
•  Advocate use of checklists
•  Annual Staff Training/In-service
•  Mock stroke drills
•  Time out before drug administration & procedures
•  Adhere to guidelines
•  Frequent monitoring before, during and after changes
•  Focused performance improvement
•  Collect and feed forward process and outcome data
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Summary of 
Differences from FDA 
Recommendations
•  Warnings:  Age > 80  
•  NIH Stroke Scale > 25
•  Previous history of stroke and diabetes
•  Any anticoagulant use even if INR < 1.7





Age, 18 to 80 years
Onset of stroke symptoms 3 to 4.5 hours before initiation of study-drug administration
Stroke symptoms present for at least 30 minutes with no sigificant improvement before treatment
Main exclusion criteria
Intracranial hemorrhage
Time of symptom onset unknown
Symptoms rapidly improving or only minor before start of infusion
Severe stroke as assessed clinically (e.g. NIHSS score >25) or by appropriate imaging techniques*
Seizure at the onset of stroke
Stroke or serious head trauma within the previous 3 months
Combination of previous stroke and diabetes mellitus
Administration of heparin within the 48 hours preceding the onset of stroke, with an activated partial-
thromboplastin time at presentation exceeding the upper limit of the normal range
Platelet count of less than 100,000 per cubic millimeter
Systolic pressure greater than 185 mm Hg or diastolic pressure greater than 110 mm Hg or aggressive treatment 
(intravenous medication) necessary to reduce blood pressure to these limits
Blood glucose less than 50 mg per deciliter or greater than 400 mg per deciliter
Symptoms suggestive or subarachnoid hemorrhage, even if CT scan was normal
Oral anticoagulant treatment
Major surgery or severe trauma within the previous 3 months
Other major disorders associated with an increased risk of bleeding
A severe stroke as assesed by imaging was defined as a stroke involving more than one third of the middle cerebral 
artery territory. NIHSS denotes National Institutes of Health Stroke Scale in which total scores range from 0 to 42 
with higher values reflecting more severe cerebral infarcts.
Major Inclusion and Exclusion Criteria
Stroke treatment is rapidly changing.  Nurses need to understand 
cerebrovascular pathophysiology and available options for reperfusion 
interventions.  Advances in neuro imaging will aide in better 
patient selection for emerging new therapies with goal to open 
blood vessels faster.  Clear communication is essential and 
includes hand offs, medication reconciliation, nurse to nurse 
neuro exams and individualized plans of care.
Nursing Implications for Practice:
Computed Tomography:
Non Contrast CT remains the “gold standard”in acute ischemic stroke.
Multi modality CT with CT perfusion/ CT angiography can provide info on 
cerebral blood volume, blood flow and mean transit time helping to identify 
ischemic core and penumbra.
Magnetic Resonance Imaging:
Earliest evidence of ischemic injury and evaluates extracranial and intracranial 
blood vessels. Use of diffusion weighted and perfusion weighted imaging 
provides further advantages of defining ischemic area and hemodynamic 
status of cerebral blood flow.  Tissue mismatch can be utilized to identify 
salvageable brain. 
Carotid duplex scanning used to screen for cervical internal carotid 
artery stenosis.
Cerebral arteriography is the best tool to definitively evaluate the 
cerebral vasculature for stenosis and changes in blood flow dynamics.
Use of Imaging to Guide Clinical Decisions:
*Taken from Hacke et al (2008).
Tissue Status: Perfusion Status: Vessel Status:
Maximum Intervals Recommended by NINDS Time
Door-to-doctor first sees patient 10 min
Door-to-CT completed 25 min
Door-to-CT read 45 min
Door-to-thrombolytic therapy starts 60 min
Physician examination 15 min
Neurosurgical expertise available* 2 h
Admitted to monitored bed 3 h
  
Stroke-1 Deep vein thrombosis prophylaxis
Stroke-2 Discharged on antithrombotic therapy
Stroke-3 Patients with atrial fibrillation receiving anticoagulation therapy
Stroke-4 Thrombolytic therapy administered
Stroke-5 Antithrombotic therapy by end of hospital day two




Stroke-10 Assessed for rehabilitation
NINDS Time Targets for Organized Triage of 
Acute Stroke Patients: Key Evaluation Time 
Targets for the Potential rtPA Candidate
*Taken from Summers et al (2009)
Performance Measures From the Joint Commission 
Primary Stroke Center Certification Program
Commonly Measured Acute Stroke Metrics:
CT indicates computed tomography
*On-site or by transfer to another facility
